Profil
Brian C.
Keller is the founder of BioZone Laboratories, Inc., which was founded in 1987.
He currently holds the title of Chief Scientific Officer & Executive VP at BioZone Laboratories, Inc. In addition to his founding position, Dr. Keller also held the position of President, Director & Chief Scientific Officer at BioZone Pharmaceuticals, Inc. from 2011 to 2014.
Dr. Keller received his undergraduate degree from the University of California San Diego in 1979 and his doctorate degree from The University of California, San Francisco in 1983.
Postes actifs de Brian C. Keller
| Sociétés | Poste | Début |
|---|---|---|
BioZone Laboratories, Inc.
BioZone Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets over the counter drugs | Fondateur | 01/01/1987 |
Anciens postes connus de Brian C. Keller
| Sociétés | Poste | Fin |
|---|---|---|
BioZone Pharmaceuticals, Inc.
BioZone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | President | 02/01/2014 |
Formation de Brian C. Keller
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
BioZone Laboratories, Inc.
BioZone Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets over the counter drugs | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioZone Pharmaceuticals, Inc.
BioZone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | Health Technology |
















